ライフサイエンスコーパス: squamous

1 oup and n=110 in the docetaxel group) or non-squamous (0.73 [0.60-0.89]; n=313 and n=315) histology.

2 Results Of patients, 648 were recruited (177 squamous, 471 nonsquamous).

3 scopic diagnosis and treatment of dysplasia (squamous and Barrett's), and early esophageal cancer usi

4 Human esophageal squamous cancer cells were transduced with luciferase le

5 -promoting properties in an in vivo model of squamous cancer-stromal cell expansion.

6 Squamous cancers can be treated with primary chemoradiot

7 py in a rat model with orthotopic esophageal squamous cancers.

8 ular and microenvironmental context in which squamous carcinogenesis occurs.

9 an ovarian cancer cell line A2780, the human squamous carcinoma cell line Cal27, and their cisplatin

10 cancer cells, and LU-HNSCC-25 head and neck squamous carcinoma cells in phosphate buffered saline.

11 -SDT) could induce apoptosis in human tongue squamous carcinoma SAS cells through mitochondrial pathw

12 ote invasion and metastasis in head and neck squamous carcinomas (HNSCCs), a finding that unveils new

13 ct the epidermis from tumorigenesis and that squamous carcinomas are sensitive to inhibition of PPAR-

14 upon combined deletion of Dnmt3a and Dnmt3b, squamous carcinomas become more aggressive and metastati

15 proto-oncogene MYC is frequently altered in squamous carcinomas, but this is insufficient to drive c

16 ost-progression tumour samples, we found one squamous cell and two small-cell transformations.

17 rd of care in locally advanced head and neck squamous cell cancer (LAHNSCC).

18 ment for Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Cancer (LSCC) and the ERK2-VTX11e treatmen

19 ly when applied to HPV-related oropharyngeal squamous cell cancer (OPSCC), leading to calls for a new

20 esistant colorectal cancer and head and neck squamous cell cancer cell lines and in tumors from color

21 ed by its pathogenic mutations in esophageal squamous cell cancers (SCCs).

22 nce the effect of chemotherapy on esophageal squamous cell cancers.

23 multiple genes that are mutated in cutaneous squamous cell cancers.

24 treatment of locally advanced head and neck squamous cell cancers.

25 re being treated for basal cell carcinoma or squamous cell carcinoma (cases) and 100 individuals who

26 Perineural invasion (PNI) in cutaneous squamous cell carcinoma (CSCC) has been associated with

27 nsformation of normal epidermis to cutaneous squamous cell carcinoma (cSCC) is causally linked to alt

28 Cutaneous squamous cell carcinoma (cSCC) is one of the most common

29 Keratinocyte-derived cutaneous squamous cell carcinoma (cSCC) is the most common metast

30 ified genetic loci associated with cutaneous squamous cell carcinoma (cSCC) risk, but single-nucleoti

31 have a 100-fold increased risk of cutaneous squamous cell carcinoma (cSCC).

32 s with inoperable locally advanced cutaneous squamous cell carcinoma (cSCC).

33 -wide association study (GWAS) on esophageal squamous cell carcinoma (ESCC) in Han Chinese, we conduc

34 issues removed from patients with esophageal squamous cell carcinoma (ESCC) with poor prognosis, and

35 ophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC), although evidence is lim

36 h enhanced malignant potential in esophageal squamous cell carcinoma (ESCC), among the deadliest of a

37 have efficacy in EGFR-amplified oesophageal squamous cell carcinoma (ESCC), but may become quickly i

38 chemoresistance in patients with esophageal squamous cell carcinoma (ESCC).

39 e to chronic fungal infection and esophageal squamous cell carcinoma (ESCC).

40 define an intrinsic subtype of head and neck squamous cell carcinoma (HNSC) that features pronounced

41 Head and neck squamous cell carcinoma (HNSCC) accounts for nearly 90%

42 cetuximab in locally advanced head and neck squamous cell carcinoma (HNSCC) and biomarkers that pred

43 potential relationship between head and neck squamous cell carcinoma (HNSCC) and microbial dysbiosis,

44 is frequently overexpressed in head and neck squamous cell carcinoma (HNSCC) and other cancers.

45 to examine whether staging of head and neck squamous cell carcinoma (HNSCC) by upfront (18)F-FDG PET

46 panel of 49 established human head and neck squamous cell carcinoma (HNSCC) cell lines and report th

47 l Cell Lung Cancer (NSCLC) and Head and Neck Squamous Cell Carcinoma (HNSCC) cell lines and was due t

48 phenotypes in patient-derived head and neck squamous cell carcinoma (HNSCC) cells in vitro and in vi

49 papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) have better responses to

50 Head and neck squamous cell carcinoma (HNSCC) includes epithelial canc

51 Head and neck squamous cell carcinoma (HNSCC) is the sixth most common

52 ely 6,000 single cells from 18 head and neck squamous cell carcinoma (HNSCC) patients, including five

53 apillomavirus-related (HPV(+)) head and neck squamous cell carcinoma (HNSCC) samples.

54 e cell growth of p53-deficient head and neck squamous cell carcinoma (HNSCC) UM-SCC-1 cells both in i

55 ne and metabolic phenotypes in head and neck squamous cell carcinoma (HNSCC) were assessed and change

56 nt-resistant head and neck tumors, including squamous cell carcinoma (HNSCC), adenoid cystic carcinom

57 clinically validated target in head and neck squamous cell carcinoma (HNSCC), where EGFR-blocking ant

58 defective molecular switch in head and neck squamous cell carcinoma (HNSCC).

59 ectively inhibit the growth of head and neck squamous cell carcinoma (HNSCC).

60 the survival of patients with head and neck squamous cell carcinoma (HNSCC).

61 h the p53 family member p63 in head and neck squamous cell carcinoma (HNSCC).

62 sion is a hallmark of advanced head and neck squamous cell carcinoma (HNSCC).

63 gastric adenocarcinoma (AGS) and esophageal squamous cell carcinoma (KYSE30) cancer cells were studi

64 iling to analyze TLS formation in human lung squamous cell carcinoma (LSCC) and in an experimental mo

65 specific copy number gain (CNG) in both lung squamous cell carcinoma (LSCC) and ovarian serous carcin

66 TF), a measure of tumor invasiveness of lung squamous cell carcinoma (LSCC).

67 ibe a similar hypomethylated subtype of lung squamous cell carcinoma (LUSC) that is enriched for both

68 between lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), two main lung cancer sub

69 patients with nonoropharyngeal head and neck squamous cell carcinoma (non-OP HNSCC).

70 The incidence of HPV-related oropharyngeal squamous cell carcinoma (OPSCC) has increased more than

71 papillomavirus (HPV)-negative oropharyngeal squamous cell carcinoma (OPSCC) has shown resistance to

72 papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC) is disproportionately hi

73 Purpose Treatment of oropharyngeal squamous cell carcinoma (OPSCC) is evolving toward risk-

74 apillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) is treatment-responsive.

75 deline on radiation therapy in oropharyngeal squamous cell carcinoma (OPSCC) that was determined to b

76 Human oral squamous cell carcinoma (OSCC) constitutes an inflammato

77 FA patients develop oral squamous cell carcinoma (OSCC) earlier and more frequent

78 Oral squamous cell carcinoma (OSCC) is the most common cancer

79 ogene, ROS1, as an important driver for oral squamous cell carcinoma (OSCC) metastasis.

80 Oral squamous cell carcinoma (OSCC) patients generally have a

81 ssible association between bacteria and oral squamous cell carcinoma (OSCC) remain inconclusive, larg

82 Malignant tumors included melanoma (12%), squamous cell carcinoma (SCC) (9%), lymphoma (7%), and o

83 uded 53 patients with a history of cutaneous squamous cell carcinoma (SCC) after a first kidney trans

84 ic immunosuppression promotes nonmelanocytic squamous cell carcinoma (SCC) after kidney transplantati

85 ng keratinocyte cancers, including cutaneous squamous cell carcinoma (SCC) and basal cell carcinoma (

86 Here we document TCF7L1 upregulation in skin squamous cell carcinoma (SCC) and demonstrate that TCF7L

87 alignant skin lesions that can progress into squamous cell carcinoma (SCC) and invasive SCC if left u

88 ends in the risk of posttransplant cutaneous squamous cell carcinoma (SCC) are few and appear contrad

89 signaling mediators, but their functions in squamous cell carcinoma (SCC) are unclear.

90 Here we demonstrate for the first time that squamous cell carcinoma (SCC) EVs were enriched with the

91 fferentiating basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) from healthy tissue.

92 bution of voriconazole to the development of squamous cell carcinoma (SCC) in lung transplant recipie

93 d incidence of basal cell carcinoma (BCC) or squamous cell carcinoma (SCC) in QSkin, a prospective st

94 lta T cells protect against the formation of squamous cell carcinoma (SCC) in several models.

95 Anal squamous cell carcinoma (SCC) is associated with both hu

96 to urinary arsenic concentration and risk of squamous cell carcinoma (SCC) of the skin in a U.S. popu

97 18)F-FDG phosphorylation rate were higher in squamous cell carcinoma (SCC) than in adenocarcinoma (AC

98 Here, we report in a murine model of skin squamous cell carcinoma (SCC) that nuclear FAK regulates

99 The age-standardized incidence rate of squamous cell carcinoma (SCC) was highest among black pe

100 ophagus (BE), columnar cell metaplasia (CM), squamous cell carcinoma (SCC), and squamous epithelium (

101 s), including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), are the most common cance

102 rs for posttransplant skin cancer, including squamous cell carcinoma (SCC), melanoma (MM), and Merkel

103 Lung squamous cell carcinoma (SCC), strongly associated with

104 s) are found in many cancer types, including squamous cell carcinoma (SCC).

105 A)-induced hamster cheek pouch model of oral squamous cell carcinoma (SCC).

106 n lung adenocarcinoma (LUAD) but not in lung squamous cell carcinoma (SCC).

107 ), defined as basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).

108 r outcomes in many human tumor types such as squamous cell carcinoma (SCC).

109 Adenocarcinoma (ADC) and squamous cell carcinoma (SqCC) are the two predominant s

110 denocarcinoma (AD) project and 504 from TCGA squamous cell carcinoma (SQCC) project-were classified u

111 surgical treatment modalities for subungual squamous cell carcinoma (SUSCC) without bone invasion ne

112 prised a mixed papilloma/well-differentiated squamous cell carcinoma (wdSCC), exhibiting p53 loss, in

113 patients with non-squamous cell carcinoma or squamous cell carcinoma (without positive markers, eg, E

114 letion alleles is 50% in 143 genotyped oral squamous cell carcinoma -Taiwan samples (27A3B (-/-):89A

115 zard ratios across subgroups, including both squamous cell carcinoma and adenocarcinoma, both cN0 and

116 sive phenotypes in lung adenocarcinoma, lung squamous cell carcinoma and breast carcinoma cancer cell

117 epidermal development, psoriasis, cutaneous squamous cell carcinoma and re-epithelisation are highli

118 The most common aetiology was squamous cell carcinoma and the majority of cases (30%)

119 d its capability in quantitative analysis of squamous cell carcinoma antigen in human serum with reco

120 ak current variation to the concentration of squamous cell carcinoma antigen in the range of 0.001-0.

121 volved in the progression of transition zone squamous cell carcinoma are poorly understood, hence rep

122 The aim of this article is to describe oral squamous cell carcinoma as it appears in different imagi

123 ith histologically verified primary head and squamous cell carcinoma at Odense University Hospital fr

124 in the pharyngeal mucosal space (n=16) with squamous cell carcinoma being the most common pathology.

125 tients treated by chemoradiotherapy for anal squamous cell carcinoma between October 2007 and October

126 We show here that in both squamous cell carcinoma cells and melanoma tumor cells,

127 Here, using mouse squamous cell carcinoma cells, we report a completely ne

128 GFR with GFP by genome-editing of human oral squamous cell carcinoma cells, which were used to examin

129 nd, like JunB, it was downregulated in human squamous cell carcinoma cells.

130 ted with CD44, HAS3, and ABCC1 expression in squamous cell carcinoma datasets and p63-HA pathway is a

131 But the biological effect of SDT on oral squamous cell carcinoma has not been studied.

132 lopment of UV irradiation-mediated cutaneous squamous cell carcinoma in mice.

133 ential therapeutic targets for prevention of squamous cell carcinoma in patients with Kindler syndrom

134 Oesophageal squamous cell carcinoma is a deadly disease where system

135 Esophageal squamous cell carcinoma is a major histological type of

136 y genomic studies in other cancer types.Oral squamous cell carcinoma is a prevalent malignancy in Tai

137 Oral squamous cell carcinoma is a prominent cancer worldwide,

138 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes.

139 randomized trials on secondary prevention of squamous cell carcinoma observed a reduction in cumulati

140 ffect radiotherapy response and prognosis of squamous cell carcinoma of oropharynx (SCCOP).

141 Squamous cell carcinoma of the anal canal (SCCA) is a ra

142 Purpose Squamous cell carcinoma of the anal canal (SCCAC) is cha

143 In patients with squamous cell carcinoma of the anus (SCCA), lymph node p

144 se after chemoradiotherapy for patients with squamous cell carcinoma of the anus is 26 weeks from sta

145 the quality of outcome reporting in RCTs of squamous cell carcinoma of the anus is inconsistent.

146 h newly diagnosed, histologically confirmed, squamous cell carcinoma of the anus without metastatic d

147 ) of radical chemoradiation for treatment of squamous cell carcinoma of the anus.

148 chemoradiotherapy in locoregionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN).

149 ucleus enhanced its interaction with PCNA in squamous cell carcinoma of the head and neck (SCCHN) cel

150 logically confirmed recurrent and metastatic squamous cell carcinoma of the head and neck after disea

151 ositol 3-kinase (PI3K) pathway activation in squamous cell carcinoma of the head and neck contributes

152 platinum-refractory recurrent or metastatic squamous cell carcinoma of the head and neck have few tr

153 ial in patients with recurrent or metastatic squamous cell carcinoma of the head and neck who progres

154 fe for patients with recurrent or metastatic squamous cell carcinoma of the head and neck, these data

155 platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck.

156 platinum-refractory recurrent or metastatic squamous cell carcinoma of the head and neck.

157 ebo in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

158 d in 2004 to 2012 with AJCC stage III to IVB squamous cell carcinoma of the oral cavity, oropharynx,

159 had to include patients with non-metastatic squamous cell carcinoma of the oral cavity, oropharynx,

160 g first-line treatment for patients with non-squamous cell carcinoma or squamous cell carcinoma (with

161 was more apparent in adenocarcinoma than in squamous cell carcinoma patients.

162 rofile in recurrent/metastatic head and neck squamous cell carcinoma previously treated with platinum

163 ments for recurrent/metastatic head and neck squamous cell carcinoma refractory to platinum and cetux

164 from the 1000 Genomes Project and esophageal squamous cell carcinoma samples show that seeksv has hig

165 illary urothelial carcinoma, small cell, and squamous cell carcinoma subtypes of invasive bladder can

166 However, the mechanisms underlying squamous cell carcinoma susceptibility are unclear.

167 hat SNP309G allele actually protects against squamous cell carcinoma susceptibility.

168 tion germline polymorphism in Taiwanese oral squamous cell carcinoma that impacts expression of APOBE

169 of zinc on cell proliferation in esophageal squamous cell carcinoma through Orai1.

170 In mice bearing esophageal squamous cell carcinoma tumors, to estimate uptake (K),

171 Methods Adult patients with oral cavity squamous cell carcinoma undergoing upfront surgical rese

172 with subgroup analyses by histological type (squamous cell carcinoma vs adenocarcinoma) and type of n

173 and in the prestyloid parapharyngeal space, squamous cell carcinoma were the most common lesions, re

174 t in non-Hispanic whites, whereas esophageal squamous cell carcinoma with risk factors of tobacco and

175 dependence on the required imaging label in squamous cell carcinoma xenografts.

176 ophageal cancer (84.7% adenocarcinoma, 15.2% squamous cell carcinoma), 335 (9.3%) were treated with A

177 eal adenocarcinomas, 323 cases of esophageal squamous cell carcinoma, 698 cases of gastric cardia ade

178 increase was seen in Bowen disease, invasive squamous cell carcinoma, and a superficial type of basal

179 monstrates PD-L1 detection in NSCLC, breast, squamous cell carcinoma, and melanoma.

180 in lung adenocarcinoma as compared with lung squamous cell carcinoma, and that neutrophils are the mo

181 In addition to esophageal squamous cell carcinoma, cancers of the small bowel, pan

182 dvantage on normal and neoplastic (cutaneous squamous cell carcinoma, cSCC) human epidermal cells.

183 Critically, in head and neck squamous cell carcinoma, Fxr1 overexpression correlates

184 lanoma skin cancers, in particular cutaneous squamous cell carcinoma, have the highest standardized i

185 man papilloma virus-associated oropharyngeal squamous cell carcinoma, we hypothesized that adding cet

186 Squamous cell carcinoma-related oncogene (SCCRO)/DCUN1D1

187 t to CHCT/MRI in patients with head and neck squamous cell carcinoma.

188 ctinic keratosis is a precursor to cutaneous squamous cell carcinoma.

189 ochemistry in 96 patients with head and neck squamous cell carcinoma.

190 of Tgfbr2-deficient invasive transition zone squamous cell carcinoma.

191 poor prognosis in melanoma and head and neck squamous cell carcinoma.

192 r smokers and in participants diagnosed with squamous cell carcinoma.

193 rom the HF junctional zone and predispose to squamous cell carcinoma.

194 vival of five cancers, such as head and neck squamous cell carcinoma.

195 keratinocytes, the cell-type susceptible to squamous cell carcinoma.

196 prostate cancer, urothelial cancer, and skin squamous cell carcinoma.

197 associated with skin keratosis and cutaneous squamous cell carcinoma.

198 ll proportion of the disease can progress to squamous cell carcinoma.

199 ity, photosensitivity, and increased risk of squamous cell carcinoma.

200 candidiasis, hypothyroidism, and esophageal squamous cell carcinoma.

201 up-regulated in human actinic keratosis and squamous cell carcinoma.

202 ma, esophageal adenocarcinoma, or esophageal squamous cell carcinoma.Among older American adults, bot

203 was recently proposed for advanced cutaneous squamous cell carcinomas (cSCC); however, its efficacy i

204 as (EACs) and EGFR overexpressing esophageal squamous cell carcinomas (ESCCs).

205 Head and neck squamous cell carcinomas (HNSCC) exhibiting resistance t

206 ed by stromal fibroblasts from head and neck squamous cell carcinomas (HNSCC).

207 papillomavirus (HPV)-negative head and neck squamous cell carcinomas (HNSCCs) are deadly and common

208 Head and neck squamous cell carcinomas (HNSCCs) are refractory to ther

209 owever, more recent studies of head and neck squamous cell carcinomas (HNSCCs) suggest that integrati

210 tures unique to human oral and oropharyngeal squamous cell carcinomas (OCSCC/OPSCC).

211 es an increasing proportion of oropharyngeal squamous cell carcinomas (OPSCCs), particularly in white

212 The associations were somewhat stronger in squamous cell carcinomas (SCC, OR = 4.90) than in urothe

213 Keratinocyte carcinomas (KCs), consisting of squamous cell carcinomas (SCCs) and basal cell carcinoma

214 Squamous cell carcinomas (SCCs) are heterogeneous tumors

215 Squamous cell carcinomas (SCCs) derived from interfollic

216 gs cooperate to act as a tumor suppressor in squamous cell carcinomas (SCCs).

217 Oral squamous cell carcinomas are a major cause of morbidity

218 Squamous cell carcinomas occurring at transition zones a

219 The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of Head and neck (MARCH) showed

220 nt CRT regimens for both adenocarcinomas and squamous cell carcinomas of the esophagus.

221 Squamous cell carcinomas of the head and neck (SCCHN) af

222 e establishes a chromatin state predisposing squamous cell carcinomas to undergo EMT and metastasis,

223 Using 313 adenocarcinomas and 138 squamous cell carcinomas with genetically supported ance

224 r tumors specimens (319 adenocarcinomas; 142 squamous cell carcinomas) were profiled from 245 black p

225 which were frequently dysregulated in human squamous cell carcinomas, highlighting their potential a

226 al sources are lacking, such as in basal and squamous cell carcinomas, which are not included in nati

227 ed in national registries, such as basal and squamous cell carcinomas.

228 metimes with keratin pearls, consistent with squamous cell carcinomas.

229 ting toxicity in patients with head and neck squamous cell carcinomas.

230 e (PI3Kalpha), are frequent in head and neck squamous cell carcinomas.

231 atients who were EGFR FISH non-positive with squamous cell histology (HR 1.04, 95% CI 0.78-1.40; p=0.

232 Squamous cell histology was reported for 422 (28%) of 15

233 sis of EGFR FISH-positive subpopulation with squamous cell histology, overall survival was significan

234 -cell lung cancer (NSCLC), particularly with squamous cell histology.

235 -C is also associated with increased risk of squamous cell lung carcinoma in the International Lung C

236 65 patients with melanoma, lung nonsquamous, squamous cell lung or head and neck cancers who were tre

237 on at the MTD, patients with FGFR1-amplified squamous cell non-small-cell lung cancer (sqNSCLC; arm 1

238 4Nx-0M0 or pT1-4N1-3M0 esophageal carcinoma (squamous cell or adenocarcinoma) from 1998 to 2011 treat

239 because a small proportion can progress into squamous cell skin cancer.

240 arms for either histology (adenocarcinoma or squamous cell).

241 half of the world's 500,000 new oesophageal squamous-cell carcinoma (ESCC) cases each year occur in

242 analyses of patients with EGFR FISH-positive squamous-cell carcinoma cancers are encouraging and supp

243 wly diagnosed, biopsy-proven stage III or IV squamous-cell carcinoma of the oropharynx, positive for

244 have recurrent copy-number variants in three squamous-cell carcinomas (oesophageal, head and neck and

245 Studies involving women with atypical squamous cells of undetermined significance (ASC-US) or

246 mal cytological findings; 1784 with atypical squamous cells of undetermined significance (ASCUS); 217

247 us (HPV) triage of cytology showing atypical squamous cells of undetermined significance (hereafter A

248 lineage tracing strategies to show that this squamous-columnar junction basal cell population serves

249 ogenitor cells (p63(+)KRT5(+)KRT7(+)) at the squamous-columnar junction of the upper gastrointestinal

250 tt's oesophagus progression sequence (normal squamous controls [n=20], non-dysplastic [n=24] and dysp

251 ent of Wnt activated mammary carcinomas with squamous differentiation was accompanied by a significan

252 tes, resulting in impaired cell division and squamous differentiation.

253 ion of TGFbeta-VAV1 signalling decreased the squamous/EMT-like cancer cells, promoted nuclear VAV1 lo

254 drive terminal differentiation in stratified squamous epithelia.

255 The presence of low numbers of squamous epithelial cells (SECs) and high numbers of pol

256 e species in their ability to infect vaginal squamous epithelial cells in vivo independently of proxi

257 (AHRR) locus, which is observed in blood and squamous epithelial cells of smokers, but not in lung ca

258 608 (69.1%) met the quality criterion of <10 squamous epithelial cells per low-power field, and 1162

259 darum readily colonized and infected vaginal squamous epithelial cells, whereas C. trachomatis did no

260 ma (PDAC) difficult to treat, especially the squamous/epithelial-to-mesenchymal transition (EMT)-like

261 sia (CM), squamous cell carcinoma (SCC), and squamous epithelium (SE) cases.

262 he esophageal lumen is lined by a stratified squamous epithelium comprised of proliferative basal cel

263 sa of patients with ERD, and the distal-most squamous epithelium of patients with BE.

264 gastrointestinal tract, particularly in the squamous epithelium of the esophagus.

265 erstanding of the mechanisms by which normal squamous epithelium progresses to early-stage invasive c

266 astro-oesophageal junction, where stratified squamous epithelium transitions into simple columnar cel

267 surface of the implant exhibited stratified squamous epithelium with sparse cilia.

268 6; p=0.88 respectively) or patients with non-squamous histology regardless of EGFR FISH status (for E

269 Patients with squamous histology were randomly assigned to cisplatin a

270 ior outcomes were observed for patients with squamous histology who received platinum therapy compare

271 stage IIIB or IV NSCLC with squamous or non-squamous histology, measurable disease by Response Evalu

272 s NSCLC and carboplatin plus gemcitabine for squamous histology.

273 groups (median age, 61 years; 65% male; 40% squamous histology; median radiation dose, 63.0 Gy), and

274 groups (median age, 63 years; 65% male; 40% squamous histology; median radiation dose, 64.6 Gy).

275 val improvement was similar in patients with squamous (HR 0.73 [95% CI 0.54-0.98]; n=112 in the atezo

276 nce was conferred by NEK6 were predominantly squamous in histology with no evidence of AR signaling.

277 ollowing outcomes: high-risk HPV prevalence; squamous intraepithelial lesion (SIL) or cervical intrae

278 omen have a higher burden of anal high-grade squamous intraepithelial lesions (HSIL) and anal cancer

279 2173 with low-grade and 1282 with high-grade squamous intraepithelial lesions (HSILs) diagnosed cytol

280 etermined significance (ASC-US) or low-grade squamous intraepithelial lesions (LSIL) who were triaged

281 roportion increased through ASCUS, low-grade squamous intraepithelial lesions, CIN1, and CIN2 (18%-25

282 t5(+)) basal cells and ectopic expression of squamous-like differentiation markers.

283 H3K27me3 and gain of H3K27ac and H3K4me3 at squamous lineage genes, including Sox2, DeltaNp63 and Ng

284 The pathobiology of early squamous lung cancer is poorly understood.

285 ths of age, had uterine neoplasms comprising squamous metaplasia, adenofibroma and adenomyoma.

286 Methods Patients with stage IIIB/IV squamous (N = 272) or nonsquamous (N = 582) NSCLC and di

287 pare the surgical outcomes of ocular surface squamous neoplasia (OSSN) following wide excisional biop

288 We enrolled patients who had squamous or non-squamous non-small-cell lung cancer, were 18 years or ol

289 ab; 10 (37%) of 27 confirmed responders with squamous NSCLC and 19 (34%) of 56 with nonsquamous NSCLC

290 16% to 30%) versus 8% (95% CI, 4% to 13%) in squamous NSCLC and 29% (95% CI, 24% to 34%) versus 16% (

291 tients with stage IIIB/IV ALK-rearranged non-squamous NSCLC was done in 134 centres across 28 countri

292 num-based chemotherapy in advanced-stage non-squamous NSCLC.

293 ts had confirmed stage IIIB or IV NSCLC with squamous or non-squamous histology, measurable disease b

294 We enrolled patients who had squamous or non-squamous non-small-cell lung cancer, wer

295 in previously treated patients with advanced squamous or nonsquamous non-small-cell lung cancer (NSCL

296 Accrual stopped early in 2012 for squamous patients because OS for nonplatinum therapy was

297 ates were 54.5% and 76.7% in nonsquamous and squamous patients, respectively, and the corresponding X

298 r LGR4, who show increased susceptibility to squamous tumor development.

299 and cell cycle pathways, whereas esophageal squamous tumors have a distinct set of mutations.

300 b-increases the number of carcinogen-induced squamous tumors, without affecting tumor progression.